• Investing Ideas
  • /
  • Global Pharmaceuticals & Biotech High Growth Potential Companies
518 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

ORY

Oryzon Genomics
€1.71-1.8%-22.3%€98.5m€6.84PB1.2xE60.6%n/a

BIOG B

BioGaia
kr133.805.2%41.9%kr13.5bkr140.00PE37xE8.9%5.2%

BVX

BiVictriX Therapeutics
UK£0.120%-16.1%UK£9.7mn/aPB3.4xE63.8%n/a

ALK B

ALK-Abelló
kr.124.10-2.9%18.5%kr.27.4bkr.125.00PE56.5xE31.0%0%

ZEAL

Zealand Pharma
kr.681.50-1.3%176.8%kr.42.4bkr.754.29PS123.8xE44.4%n/a

LONN

Lonza Group
CHF535.405.1%-0.1%CHF39.8bCHF552.43PE60.8xE19.6%0.7%

EAPI

Euroapi
€2.715.6%-73.0%€257.3m€4.72PB0.3xE93.2%n/a

CANTA

Cantargia
kr3.07-0.2%-53.9%kr564.7mkr12.67PB3.3xE60.1%n/a

DMAC

DiaMedica Therapeutics
US$2.65-4.3%80.3%US$100.6mUS$7.00PB2xE26.8%n/a

ASRT

Assertio Holdings
US$0.99-4.8%-84.3%US$94.0mUS$3.00PB0.7xE144.9%n/a

NVAX

Novavax
US$4.850.4%-27.2%US$678.8mUS$15.40PE-1.2xE75.4%n/a

VRTX

Vertex Pharmaceuticals
US$417.321.3%32.8%US$107.8bUS$459.71PE29.8xE11.2%n/a

BIO

Bio-Rad Laboratories
US$349.563.9%-25.9%US$9.9bUS$435.73PS3.7xE81.3%n/a

AYTU

Aytu BioPharma
US$3.086.6%43.9%US$17.1mUS$8.00PB0.5xE96.6%n/a

PBH

Prestige Consumer Healthcare
US$72.63-1.0%18.1%US$3.6bUS$74.33PS3.2xE34.5%n/a

RVTY

Revvity
US$105.410.7%-18.5%US$13.0bUS$123.11PE72.5xE24.1%0.3%

ANIP

ANI Pharmaceuticals
US$69.692.2%77.2%US$1.4bUS$79.80PE88.8xE37.4%n/a

SYNH

Syneos Health
US$42.980.6%-8.8%US$4.5bUS$42.63PE62.6xE33.7%n/a

4577

Daito PharmaceuticalLtd
JP¥2,343.004.0%4.5%JP¥36.7bJP¥3,155.00PE10.8xE11.3%2.6%

GLENMARK

Glenmark Pharmaceuticals
₹962.452.2%116.1%₹271.6b₹923.00PS2.1xE58.8%0.3%

A006280

GC Biopharma
₩125,400.001.0%1.6%₩1.4t₩145,000.00PB1.1xE106.4%1.2%

STAR

Strides Pharma Science
₹775.101.7%165.7%₹71.2b₹830.50PS1.8xE112.8%0.2%

A170900

Dong-A ST
₩76,600.005.1%46.0%₩649.7b₩80,957.52PE58.4xE47.5%0.9%

600436

Zhangzhou Pientzehuang Pharmaceutical
CN¥230.88-2.0%-18.0%CN¥139.3bCN¥295.86PE50xE20.8%0.5%
Page 20 of 22
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.